Literature DB >> 8789038

Direct identification and recognition of yeast species from clinical material by using albicans ID and CHROMagar Candida plates.

C Baumgartner1, A M Freydiere, Y Gille.   

Abstract

Two chromogenic media, Albicans ID and CHROMagar Candida agar plates, were compared with a reference medium, Sabouraud-chloramphenicol agar, and standard methods for the identification of yeast species. This study involved 951 clinical specimens. The detection rates for the two chromogenic media for polymicrobial specimens were 20% higher than that for the Sabouraud-chloramphenicol agar plates. The rates of identification of Candida albicans for Albicans ID and CHROMagar Candida agar plates were, respectively, 37.0 and 6.0% after 24 h of incubation and 93.6 and 92.2% after 72 h of incubation, with specificities of 99.8 and 100%. Furthermore, CHROMagar Candida plates identified 13 of 14 Candida tropicalis and 9 of 12 Candida krusei strains after 48 h of incubation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8789038      PMCID: PMC228820          DOI: 10.1128/jcm.34.2.454-456.1996

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

2.  Evaluation of Albicans ID plates.

Authors:  C De Champs; B Lebeau; P Ambroise-Thomas; R Grillot
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

3.  Evaluation of four commercial systems for identification of medically important yeasts.

Authors:  I Schuffenecker; A Freydière; H de Montclos; Y Gille
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

Review 4.  Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.

Authors:  V J Fraser; M Jones; J Dunkel; S Storfer; G Medoff; W C Dunagan
Journal:  Clin Infect Dis       Date:  1992-09       Impact factor: 9.079

Review 5.  Oral Candida in HIV infection and AIDS: new perspectives/new approaches.

Authors:  D C Coleman; D E Bennett; D J Sullivan; P J Gallagher; M C Henman; D B Shanley; R J Russell
Journal:  Crit Rev Microbiol       Date:  1993       Impact factor: 7.624

6.  Evaluation of the albicans IDR plate method for the rapid identification of Candida albicans.

Authors:  V Lipperheide; L Andraka; J Pontón; G Quindós
Journal:  Mycoses       Date:  1993 Nov-Dec       Impact factor: 4.377

7.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species.

Authors:  F C Odds; R Bernaerts
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

8.  Fluconazole-resistant Candida albicans.

Authors:  D J Boken; S Swindells; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1993-12       Impact factor: 9.079

9.  Rapid identification of Candida albicans by using Albicans ID and fluoroplate agar plates.

Authors:  P Rousselle; A M Freydiere; P J Couillerot; H de Montclos; Y Gille
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

Review 10.  Resistance of yeasts to azole-derivative antifungals.

Authors:  F C Odds
Journal:  J Antimicrob Chemother       Date:  1993-04       Impact factor: 5.790

View more
  32 in total

1.  Evaluation of CHROMagar Candida plates.

Authors:  A M Freydiere
Journal:  J Clin Microbiol       Date:  1996-08       Impact factor: 5.948

2.  Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans.

Authors:  C K Campbell; A D Holmes; K G Davey; A Szekely; D W Warnock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

3.  Evaluation of BBL CHROMagar orientation medium for detection and presumptive identification of urinary tract pathogens.

Authors:  K A Hengstler; R Hammann; A M Fahr
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

4.  Use of amplified fragment length polymorphism analysis to identify medically important Candida spp., including C. dubliniensis.

Authors:  A Borst; B Theelen; E Reinders; T Boekhout; A C Fluit; P H M Savelkoul
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

5.  Comparison of the rapid yeast plus panel with the API20C yeast system for identification of clinically significant isolates of Candida species.

Authors:  J S Heelan; E Sotomayor; K Coon; J B D'Arezzo
Journal:  J Clin Microbiol       Date:  1998-05       Impact factor: 5.948

6.  Membrane filtration test for rapid presumptive differentiation of four Candida species.

Authors:  T G Bauters; R Peleman; M Moerman; H Vermeersch; D de Looze; L Noens; H J Nelis
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

7.  Performance of selective and differential media in the primary isolation of yeasts from different biological samples.

Authors:  Jaqueline Otero Silva; Silvio Antônio Franceschini; Marco Aurélio Sicchiroli Lavrador; Regina Célia Candido
Journal:  Mycopathologia       Date:  2004-01       Impact factor: 2.574

8.  Routine use of a commercial test, GLABRATA RTT, for rapid identification of Candida glabrata in six laboratories.

Authors:  A M Freydiere; J D Perry; O Faure; B Willinger; A M Tortorano; A Nicholson; J Peman; P E Verweij
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

9.  Production of white colonies on CHROMagar Candida medium by members of the Candida glabrata clade and other species with overlapping phenotypic traits.

Authors:  Justin A Bishop; Nancy Chase; Richard Lee; Cletus P Kurtzman; William G Merz
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

10.  Routine use of a one minute trehalase and maltase test for the identification of Candida glabrata in four laboratories.

Authors:  M A Piens; J D Perry; H Raberin; F Parant; A M Freydière
Journal:  J Clin Pathol       Date:  2003-09       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.